Literature DB >> 18354419

IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.

F Weber1, B Fontaine, I Cournu-Rebeix, A Kroner, M Knop, S Lutz, F Müller-Sarnowski, M Uhr, T Bettecken, M Kohli, S Ripke, M Ising, P Rieckmann, D Brassat, G Semana, M-C Babron, S Mrejen, C Gout, O Lyon-Caen, J Yaouanq, G Edan, M Clanet, F Holsboer, F Clerget-Darpoux, B Müller-Myhsok.   

Abstract

Multiple sclerosis (MS) is the most common chronic inflammatory neurologic disorder diagnosed in young adults and, due to its chronic course, is responsible for a substantial economic burden. MS is considered to be a multifactorial disease in which both genetic and environmental factors intervene. The well-established human leukocyte antigen (HLA) association does not completely explain the genetic impact on disease susceptibility. However, identification and validation of non-HLA-genes conferring susceptibility to MS has proven to be difficult probably because of the small individual contribution of each of these genes. Recently, associations with two single nucleotide polymorphisms (SNPs) in the IL2RA gene (rs12722489, rs2104286) and one SNP in the IL7RA gene (rs6897932) have been reported by several groups. These three SNPs were genotyped in a French and a German population of MS patients using the hME assay by the matrix-assisted laser desorption/ionization time of flight technology (Sequenom, San Diego, CA, USA). We show that these SNPs do contribute to the risk of MS in these two unrelated European MS patient populations with odds ratios varying from 1.1 to 1.5. The discovery and validation of new genetic risk factors in independent populations may help toward the understanding of MS pathogenesis by providing valuable information on biological pathways to be investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354419     DOI: 10.1038/gene.2008.14

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  32 in total

1.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

2.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

Review 3.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

4.  Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.

Authors:  María L Cavanillas; Antonio Alcina; Concepción Núñez; Virginia de las Heras; Miguel Fernández-Arquero; Manuel Bartolomé; Emilio G de la Concha; Oscar Fernández; Rafael Arroyo; Fuencisla Matesanz; Elena Urcelay
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

5.  IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Authors:  Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

6.  Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.

Authors:  Claire Dandine-Roulland; Hervé Perdry
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

7.  Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.

Authors:  Kaiyu Jiang; Haeja Kessler; Yungki Park; Marc Sudman; Susan D Thompson; James N Jarvis
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

8.  IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Authors:  Lisa M Maier; Christopher E Lowe; Jason Cooper; Kate Downes; David E Anderson; Christopher Severson; Pamela M Clark; Brian Healy; Neil Walker; Cristin Aubin; Jorge R Oksenberg; Stephen L Hauser; Alistair Compston; Stephen Sawcer; Philip L De Jager; Linda S Wicker; John A Todd; David A Hafler
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917

9.  Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.

Authors: 
Journal:  Hum Mol Genet       Date:  2009-12-09       Impact factor: 6.150

10.  Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis.

Authors:  J L McCauley; R L Zuvich; Y Bradford; S J Kenealy; N Schnetz-Boutaud; S G Gregory; S L Hauser; J R Oksenberg; D P Mortlock; M A Pericak-Vance; J L Haines
Journal:  Genes Immun       Date:  2009-07-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.